Directory
>
Connie Louie-Tse
Connie Louie-Tse
Executive Director | Nektar Therapeutics
San Francisco, California, United States
Connie Louie-Tse
Summary
Connie Louie-Tse is an accomplished executive in the field of clinical data management, currently serving as the Executive Director at Nektar Therapeutics. With over two decades of experience, she has a robust background in clinical development, data management, and compliance with regulatory standards such as 21 CFR Part 11. Her career trajectory showcases a steady rise through various leadership roles at Nektar, where she has been instrumental in advancing clinical trials in oncology and infectious diseases. Connie's expertise encompasses a wide range of areas including clinical monitoring, computer system validation, and SOP development. She is passionate about leveraging technology to enhance clinical research processes and improve patient outcomes. A graduate of the University of California, Berkeley, she holds a degree in Cellular and Molecular Biology. Connie is known for her strategic vision and ability to foster collaboration across multidisciplinary teams, making her a key asset in any organization.
Connie Louie-Tse
Work Experience
Executive Director at
Nektar Therapeutics
January 2023 - Present
Senior Director, Clinical Data Management at
Nektar Therapeutics
July 2020 - January 2023
Director at
Nektar Therapeutics
July 2018 - July 2020
Associate Director at
Nektar Therapeutics
January 2016 - June 2018
Sr. Program Manager, Clinical Data Management at
Nektar Therapeutics
March 2013 - December 2015
Consultant, Clinical Data Management at
Cerexa
May 2012 - March 2013
Consultant, Clinical Data Management at
Dynavax Technologies
January 2010 - June 2012
Consultant, Global Unblinded Data Manager at
Cerexa
September 2008 - June 2009
Clinical Data Coordinator IV at
Novartis
June 2000 - February 2007
Clinical Research Associate at
IQVIA
February 1998 - May 2000
Connie Louie-Tse
Education
University of California, Berkeley, Bachelor Of Arts - Ba
Frequently Asked Questions about Connie Louie-Tse
What is Connie Louie-Tse email address?
Connie Louie-Tse's primary email address is **********@nektar.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Connie Louie-Tse work for?
Connie Louie-Tse is a Executive Director at Nektar Therapeutics.
Where Connie Louie-Tse graduated from?
Connie Louie-Tse holds a degree in Cell/Cellular And Molecular Biology from University of California, Berkeley.
How can I directly contact Connie Louie-Tse?
To contact Connie Louie-Tse directly, you can use the email address **********@nektar.com. Complete contact information is available upon registration with Muraena.
Who is Connie Louie-Tse?
Connie Louie-Tse is an accomplished executive in the field of clinical data management, currently serving as the Executive Director at Nektar Therapeutics. With over two decades of experience, she has a robust background in clinical development, data management, and compliance with regulatory standards such as 21 CFR Part 11. Her career trajectory showcases a steady rise through various leadership roles at Nektar, where she has been instrumental in advancing clinical trials in oncology and infectious diseases. Connie's expertise encompasses a wide range of areas including clinical monitoring, computer system validation, and SOP development. She is passionate about leveraging technology to enhance clinical research processes and improve patient outcomes. A graduate of the University of California, Berkeley, she holds a degree in Cellular and Molecular Biology. Connie is known for her strategic vision and ability to foster collaboration across multidisciplinary teams, making her a key asset in any organization.
Connie`s contact details
**********@nektar.com
Colleagues
Executive Director, Device Technology
SVP, Global and US Market Access
Executive Director, Recruitment
Senior Vice President, Human Resources and Facilities Operations
Vice President Quality
Vice President
Vice President of R&D QA
Executive Director, Clinical Systems & Compliance
Vice President, Biologics Development and Manufacturing
VP Corporate Development